Evaxion A (EVAX) Free Cash Flow (2020 - 2022)
Evaxion A's (EVAX) quarterly Free Cash Flow came in at -$5.1 million in Q2 2022, up 52.41% YoY from -$3.4 million in Q2 2021, and up 36.2% on a QoQ basis from -$8.0 million in Q1 2022.
Evaxion A (EVAX) Free Cash Flow (2020 - 2022) Analysis & Trends
Evaxion A (EVAX) has 3 years of Free Cash Flow data on file, last reported at -$5.1 million in Q2 2022.
- Quarterly Free Cash Flow rose 52.41% year-over-year to -$5.1 million in Q2 2022, while the trailing twelve-month figure through Mar 2023 was -$5.1 million (up 85.59% YoY) and the FY2025 annual result came in at -$8.5 million, up 35.61% from the prior year.
- Free Cash Flow climbed to -$5.1 million in Q2 2022, from -$8.0 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$2.9 million in Q1 2020 to a low of -$16.7 million in Q3 2021.
- A 3-year average of -$7.5 million and a median of -$6.6 million in 2020 frame the typical range for Free Cash Flow.
- The widest YoY moves for Free Cash Flow: up 52.41% in 2022, down 113.3% in 2022.
- Tracing EVAX's Free Cash Flow over 3 years: stood at -$7.9 million in 2020, then slumped by 110.2% to -$16.7 million in 2021, then soared by 69.41% to -$5.1 million in 2022.
- The last three Free Cash Flow figures came in at -$5.1 million (Q2 2022), -$8.0 million (Q1 2022), and -$16.7 million (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | Evaxion A | 27.61 Mn | 27.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -5.11 Mn |
| Jun 30, 2022 | -5.11 Mn |
| Mar 31, 2022 | -8.01 Mn |
| Mar 31, 2022 | -8.01 Mn |
| Sep 30, 2021 | -16.69 Mn |
| Sep 30, 2021 | -16.69 Mn |
| Jun 30, 2021 | -10.73 Mn |
| Jun 30, 2021 | -10.73 Mn |
| Mar 31, 2021 | -3.75 Mn |
| Mar 31, 2021 | -3.75 Mn |
| Sep 30, 2020 | -7.94 Mn |
| Sep 30, 2020 | -7.94 Mn |
| Jun 30, 2020 | -5.18 Mn |
| Jun 30, 2020 | -5.18 Mn |
| Mar 31, 2020 | -2.89 Mn |
| Mar 31, 2020 | -2.89 Mn |